Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive

Explore clinical trials studying Neuroectodermal Tumors, Primitive. Study availability and eligibility vary by location and protocol.

732 public trials 120 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive trial results

Recruiting

APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors

NCT05701306

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Tongji Hospital, Huazhong University of Science and Technology (HUST) Wuhan, Hubei, China
  • Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

NCT04696029

Conditions
Glioma, Medulloblastoma, Neoplasms, +7 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • Stanford University Stanford, California, United States
View all 26 locations
View Trial Details
Recruiting

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

NCT05489887

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • University of Alabama/Children's of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Rady Children's Hospital San Diego, California, United States
View all 26 locations
View Trial Details
Recruiting

SPEARHEAD-3 Pediatric Study

NCT05642455

Conditions
Fibrosarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neoplasms, +26 more
Locations
  • Stanford University Palo Alto, California, United States
  • National Institutes of Health Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View Trial Details

Related conditions